Party Like It’s 2015: Celebrate the 10th Anniversary of Timmerman Report

Luke Timmerman, founder & editor, Timmerman Report
The Timmerman Report is gearing up for the 10th Anniversary.
Time to Party!
Join a stellar cast of biotech leaders at the TR10 East Coast Party. This free and fun event will celebrate the 10th anniversary of Timmerman Report. Don’t miss the toasts and roasts of TR Founder Luke Timmerman. Listen for a few predictions about the next 10 years of biotech innovation. Enjoy music, drinks, and good company.
See you there Mar. 6 at Alnylam Pharmaceuticals headquarters in Cambridge, Mass.
REGISTER HERE
TR10 East Coast Party
Toasts / Roasts / Predictions.
- Vicki Sato, board chair, Denali Therapeutics, VIR Biotechnology
- John Maraganore, founding CEO, Alnylam Pharmaceuticals
- David Schenkein, general partner, GV
- Andy Plump, president of R&D, Takeda Pharmaceuticals
- Katrine Bosley, founding CEO, DaCapo BrainScience
- Jeremy Levin, CEO, Ovid Therapeutics
- Roger Longman, chairman, Real Endpoints
- Abe Ceesay, CEO, Rapport Therapeutics
- Reid Huber, partner, Third Rock Ventures
- Alex Harding, entrepreneur-in-residence, Atlas Venture; TR correspondent
- Jeb Keiper, CEO, Nimbus Therapeutics
- Katherine Andersen, head of life science and healthcare, HSBC USA Commercial Banking
- Christine Lindenboom, chief communications officer, Alnylam Pharmaceuticals
- David Shaywitz, biopharma R&D executive; TR healthtech columnist
- Rosana Kapeller, CEO, Rome Therapeutics
- Julie Sunderland, board member, Variant Bio, eGenesis, Horizon Surgical Systems
TR10 West Coast Party
Join a stellar cast of biotech leaders at the TR10 West Coast Party. This free and fun event will celebrate the 10th anniversary of Timmerman Report. Don’t miss the toasts and roasts of TR Founder Luke Timmerman. Listen for a few predictions about the next 10 years of biotech innovation. Enjoy music, drinks, and good company.
See you there Mar. 13 at Adaptive Biotechnologies in Seattle.
REGISTER HERE
Toasts / Roasts / Predictions.
- Thong Le, investment director, managing partner of Strategic Investment Fund, Gates Foundation; chairman, Accelerator Life Science Partners
- Bob More, managing director, Alta Partners
- Jim Olson, professor & director, Invent@Seattle Children’s Postdoctoral Scholars Program
- Sam Blackman, co-founder, Day One Biopharma
- Brad Loncar, founder, BiotechTV
- Andrew Farnum, co-founder and CEO, Variant Bio
- Aaron Ring, associate professor, Fred Hutch
- Andrew Dervan, co-founder and co-CEO, Cajal Neuroscience
- Cliff Stocks, CEO, OncoResponse
- Andy Scharenberg, co-founder and CEO, Umoja Biopharma
- Tae Han, co-founder, ProfoundBio
- Lesley Stolz, VP, early innovation partnering, J&J Innovation
- Bill Newell, CEO, Sutro Biopharma
- David Younger, co-founder and CEO, A-Alpha Bio
- Kelly O’Brien, chief philanthropy officer, Fred Hutch